Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP842518.RAGSXQX1iEKjHe4pXz9CY8wY7QRFKaTrXnrtx8vYc4Kqk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP842518.RAGSXQX1iEKjHe4pXz9CY8wY7QRFKaTrXnrtx8vYc4Kqk130_assertion type Assertion NP842518.RAGSXQX1iEKjHe4pXz9CY8wY7QRFKaTrXnrtx8vYc4Kqk130_head.
- NP842518.RAGSXQX1iEKjHe4pXz9CY8wY7QRFKaTrXnrtx8vYc4Kqk130_assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842518.RAGSXQX1iEKjHe4pXz9CY8wY7QRFKaTrXnrtx8vYc4Kqk130_provenance.
- NP842518.RAGSXQX1iEKjHe4pXz9CY8wY7QRFKaTrXnrtx8vYc4Kqk130_assertion evidence source_evidence_literature NP842518.RAGSXQX1iEKjHe4pXz9CY8wY7QRFKaTrXnrtx8vYc4Kqk130_provenance.
- NP842518.RAGSXQX1iEKjHe4pXz9CY8wY7QRFKaTrXnrtx8vYc4Kqk130_assertion SIO_000772 1701012 NP842518.RAGSXQX1iEKjHe4pXz9CY8wY7QRFKaTrXnrtx8vYc4Kqk130_provenance.
- NP842518.RAGSXQX1iEKjHe4pXz9CY8wY7QRFKaTrXnrtx8vYc4Kqk130_assertion wasDerivedFrom befree-20140225 NP842518.RAGSXQX1iEKjHe4pXz9CY8wY7QRFKaTrXnrtx8vYc4Kqk130_provenance.
- NP842518.RAGSXQX1iEKjHe4pXz9CY8wY7QRFKaTrXnrtx8vYc4Kqk130_assertion wasGeneratedBy ECO_0000203 NP842518.RAGSXQX1iEKjHe4pXz9CY8wY7QRFKaTrXnrtx8vYc4Kqk130_provenance.